According to Akero Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.56. In 2022 the company made an earnings per share (EPS) of -$2.92 a decrease over its 2021 EPS that were of -$2.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.56 | -12.33% |
2022 | -$2.92 | 1.04% |
2021 | -$2.89 | 16.53% |
2020 | -$2.48 | -29.62% |
2019 | -$3.52 | -9.05% |
2018 | -$3.87 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -14.84% | ๐บ๐ธ USA |